New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
07:02 EDTZSPHZS Pharma initiated with an Outperform at William Blair
William Blair believes management of hyperkalemia has the potential to become a significant market. The firm started shares of ZS Pharma with an Outperform rating and $75 price target.
News For ZSPH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ZSPH

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use